Placebo to match paltusotine tablets 20 mg
Sponsors
Crinetics Pharmaceuticals Inc.
Conditions
Acromegaly
Phase 3
A Randomized, Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Paltusotine in Subjects with Acromegaly Treated with Long-acting Somatostatin Receptor Ligands
Active, not recruitingCTIS2024-511925-71-00
Start: 2021-08-05Target: 20Updated: 2025-10-09
A Randomized, Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Paltusotine in Subjects with Non-pharmacologically Treated Acromegaly (PATHFNDR-2)
Active, not recruitingCTIS2024-511924-15-00
Start: 2022-04-29Target: 61Updated: 2025-11-11